drugset / Trial / NCT06625671
A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
RandomizedSequentialDouble-blindTreatment
Summary
A Phase 1/2a Study of DB-2304 in Healthy Participants and Participants with Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus
Timeline
- Start
- 2024-10-04
- Primary completion
- 2027-06-30
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DB-2304 | Unknown | — | — |
| Background | Prednisone | Other / unclassified | — | — |